Available Courses
Bridging the Gap to Reach Treatment Goals in DLBCL
Estimated Time
1 Hour
Release Date
Mar 15, 2023
Expiration Date
Feb 28, 2024
The Evolution of HCT, Part 1: Basics and Outcomes
Estimated Time
90 Minutes
Release Date
Feb 22, 2023
Expiration Date
Feb 21, 2024
The Evolution of HCT, Part 2: Eligibility
Estimated Time
45 minutes
Release Date
Feb 22, 2023
Expiration Date
Feb 21, 2024
The Evolution of HCT, Part 3: Donor Availability
Estimated Time
45 minutes
Release Date
Feb 22, 2023
Expiration Date
Feb 21, 2024
The Evolution of HCT, Part 4: Addressing Barriers
Estimated Time
30 minutes
Release Date
Feb 22, 2023
Expiration Date
Feb 21, 2024
The Evolution of HCT, Part 5: Shared Care
Estimated Time
45 minutes
Release Date
Feb 22, 2023
Expiration Date
Feb 21, 2024
Setting Up Patients for HCT and Cell Therapy Success
Estimated Time
1 Hour
Release Date
Feb 22, 2023
Expiration Date
Feb 21, 2024
Improving Survival in First-Line Metastatic NSCLC with Dual Checkpoint Blockade: Exploring Recent Data and Treatment Strategies / Activity 1
Estimated Time
30 minutes
Release Date
Feb 17, 2023
Expiration Date
Feb 16, 2024
Improving Survival in First-Line Metastatic NSCLC with Dual Checkpoint Blockade: Real-world Applications in Clinical Practice / Activity 2
Estimated Time
30 minutes
Release Date
Feb 17, 2023
Expiration Date
Feb 16, 2024
Creating Patient-centered Approaches to Optimal Care: Best Practices for Utilizing BCMA-directed Therapy
Estimated Time
30 Minutes
Release Date
Feb 09, 2023
Expiration Date
Feb 08, 2024
Navigating the Evidence: Pathways for New and Emerging BCMA Therapies
Estimated Time
30 Minutes
Release Date
Feb 02, 2023
Expiration Date
Feb 08, 2024
GVHD-E6 | ECHO Program: Supportive Care for Chronic GVHD
Estimated Time
1.0
Release Date
Feb 02, 2023
Expiration Date
Feb 02, 2024
Advancing the Standard of Care for Relapsed/Refractory Multiple Myeloma: BCMA-directed Therapy
Estimated Time
30 minutes
Release Date
Jan 26, 2023
Expiration Date
Feb 08, 2024
Managing Adverse events associated with 1L regimens for CLL and SLL
Estimated Time
0.25
Release Date
Jan 13, 2023
Expiration Date
Nov 11, 2023
AQDCE | Demystifying the Evolving Science and Potential Role of Incretins in T2D
Estimated Time
0.25 hr
Release Date
Jan 03, 2023
Expiration Date
Jan 02, 2024
AQDCE | Clinical Perspectives on Dual Checkpoint Blockade for mNSCLC
Estimated Time
0.25
Release Date
Dec 28, 2022
Expiration Date
Feb 16, 2024
GVHD-E5 | ECHO Program: Atypical Manifestations of Chronic GVHD
Estimated Time
1.0
Release Date
Dec 08, 2022
Expiration Date
Dec 08, 2023
Demystifying the Evolving Science and Potential Role of Incretins in T2D
Estimated Time
1.25 hr
Release Date
Dec 07, 2022
Expiration Date
Jan 02, 2024
CLL-SLL/MTT Episode 1 - What You MUST Know About the Emerging Standard of Care for 1L Treatment of CLL and SLL
Estimated Time
30 minutes
Release Date
Dec 01, 2022
Expiration Date
Dec 14, 2023
CLL-SLL/MTT Episode 2 - Moving Towards Fixed-Duration Therapy in CLL and SLL
Estimated Time
30 minutes
Release Date
Dec 01, 2022
Expiration Date